674 related articles for article (PubMed ID: 16267017)
41. The unhydrolyzable fenretinide analogue 4-hydroxybenzylretinone induces the proapoptotic genes GADD153 (CHOP) and Bcl-2-binding component 3 (PUMA) and apoptosis that is caspase- dependent and independent of the retinoic acid receptor.
Anding AL; Chapman JS; Barnett DW; Curley RW; Clagett-Dame M
Cancer Res; 2007 Jul; 67(13):6270-7. PubMed ID: 17616685
[TBL] [Abstract][Full Text] [Related]
42. RAR beta 2-mediated growth inhibition in HeLa cells.
Si SP; Lee X; Tsou HC; Buchsbaum R; Tibaduiza E; Peacocke M
Exp Cell Res; 1996 Feb; 223(1):102-11. PubMed ID: 8635481
[TBL] [Abstract][Full Text] [Related]
43. Response of human rhabdomyosarcoma cell lines to retinoic acid: relationship with induction of differentiation and retinoic acid sensitivity.
Ricaud S; Vernus B; Bonnieu A
Exp Cell Res; 2005 Dec; 311(2):192-204. PubMed ID: 16236281
[TBL] [Abstract][Full Text] [Related]
44. Retinoids and cancer: antitumor effect of ATRA and of a new derivative of retinoic acid, IIF, on colon carcinoma cell lines CaCo-2 and HT-29.
Bartolini G; Ammar K; Mantovani B; Scanabissi F; Ferreri AM; Rocchi P; Orlandi M
Anticancer Res; 2004; 24(3a):1779-83. PubMed ID: 15274355
[TBL] [Abstract][Full Text] [Related]
45. Cellular redox state and its relationship to the inhibition of clonal cell growth and the induction of apoptosis during all-trans retinoic acid exposure in acute myeloblastic leukemia cells.
Mäntymaa P; Guttorm T; Siitonen T; Säily M; Savolainen ER; Levonen AL; Kinnula V; Koistinen P
Haematologica; 2000 Mar; 85(3):238-45. PubMed ID: 10702810
[TBL] [Abstract][Full Text] [Related]
46. All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells.
Huang H; Wu D; Fu J; Chen G; Chang W; Chow HC; Leung AY; Liang R
Eur J Haematol; 2009 Sep; 83(3):191-202. PubMed ID: 19467017
[TBL] [Abstract][Full Text] [Related]
47. The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism.
Di Francesco AM; Meco D; Torella AR; Barone G; D'Incalci M; Pisano C; Carminati P; Riccardi R
Biochem Pharmacol; 2007 Mar; 73(5):643-55. PubMed ID: 17150196
[TBL] [Abstract][Full Text] [Related]
48. Increased expression of cyclin A1 protein is associated with all-trans retinoic acid-induced apoptosis.
Ekberg J; Brunhoff C; Järås M; Fan X; Landberg G; Persson JL
Int J Biochem Cell Biol; 2006; 38(8):1330-9. PubMed ID: 16517207
[TBL] [Abstract][Full Text] [Related]
49. Influence of the level of gamma-glutamyltranspeptidase activity on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to all-trans-retinoic acid.
Palomares T; Castro B; del Olmo M; Iglesias A; Bilbao P; Alonso-Varona A
Anticancer Drugs; 2006 Nov; 17(10):1127-39. PubMed ID: 17075312
[TBL] [Abstract][Full Text] [Related]
50. Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates.
Qi H; Ratnam M
Cancer Res; 2006 Jun; 66(11):5875-82. PubMed ID: 16740727
[TBL] [Abstract][Full Text] [Related]
51. Apoptotic and anti-proliferative effects of all-trans retinoic acid. Adenine nucleotide translocase sensitizes HeLa cells to all-trans retinoic acid.
Zamora M; Ortega JA; Alaña L; Viñas O; Mampel T
Exp Cell Res; 2006 Jun; 312(10):1813-9. PubMed ID: 16556444
[TBL] [Abstract][Full Text] [Related]
52. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
[TBL] [Abstract][Full Text] [Related]
53. Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid.
Hoffman AD; Engelstein D; Bogenrieder T; Papandreou CN; Steckelman E; Dave A; Motzer RJ; Dmitrovsky E; Albino AP; Nanus DM
Clin Cancer Res; 1996 Jun; 2(6):1077-82. PubMed ID: 9816270
[TBL] [Abstract][Full Text] [Related]
54. All-trans-retinoic acid activates caspase-1 in a dose-dependent manner in cervical squamous carcinoma cells.
Arany I; Ember IA; Tyring SK
Anticancer Res; 2003; 23(1A):471-3. PubMed ID: 12680251
[TBL] [Abstract][Full Text] [Related]
55. 1 alpha, 25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line.
Higashimoto Y; Ohata M; Nishio K; Iwamoto Y; Fujimoto H; Uetani K; Suruda T; Nakamura Y; Funasako M; Saijo N
Anticancer Res; 1996; 16(5A):2653-9. PubMed ID: 8917365
[TBL] [Abstract][Full Text] [Related]
56. Expression profiles of Id1 and p16 proteins in all-trans-retinoic acid-induced apoptosis and cell cycle re-distribution in melanoma.
Zhang H; Rosdahl I
Cancer Lett; 2005 Jan; 217(1):33-41. PubMed ID: 15596294
[TBL] [Abstract][Full Text] [Related]
57. Binding of retinoids to human breast cancer cell lines and their effects on cell growth.
Lacroix A; Lippman ME
J Clin Invest; 1980 Mar; 65(3):586-91. PubMed ID: 7188772
[TBL] [Abstract][Full Text] [Related]
58. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E
J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117
[TBL] [Abstract][Full Text] [Related]
59. Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment.
Lim SJ; Paeng JC; Kim SJ; Kim SY; Lee H; Moon DH
J Nucl Med; 2007 Mar; 48(3):398-404. PubMed ID: 17332617
[TBL] [Abstract][Full Text] [Related]
60. Retinol Increases beta-catenin-RXRalpha binding leading to the increased proteasomal degradation of beta-catenin and RXRalpha.
Dillard AC; Lane MA
Nutr Cancer; 2008; 60(1):97-108. PubMed ID: 18444141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
